HK1013299A1 - Process for manufacturing crystals of growth hormone and crystals thereby obtained - Google Patents

Process for manufacturing crystals of growth hormone and crystals thereby obtained

Info

Publication number
HK1013299A1
HK1013299A1 HK98114660A HK98114660A HK1013299A1 HK 1013299 A1 HK1013299 A1 HK 1013299A1 HK 98114660 A HK98114660 A HK 98114660A HK 98114660 A HK98114660 A HK 98114660A HK 1013299 A1 HK1013299 A1 HK 1013299A1
Authority
HK
Hong Kong
Prior art keywords
crystals
pct
date
alkyl
growth hormone
Prior art date
Application number
HK98114660A
Other languages
English (en)
Inventor
Ebba Florin-Robertsson
Elvy Hokby
Ronny Lundin
Sirkka Thome
Gertrud Westin-Sjodahl
Tomas Lundqvist
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9203175A external-priority patent/SE9203175D0/xx
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of HK1013299A1 publication Critical patent/HK1013299A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK98114660A 1992-10-28 1998-12-22 Process for manufacturing crystals of growth hormone and crystals thereby obtained HK1013299A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9203175A SE9203175D0 (sv) 1992-10-28 1992-10-28 Growth hormone
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone
PCT/SE1993/000885 WO1994010192A1 (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained

Publications (1)

Publication Number Publication Date
HK1013299A1 true HK1013299A1 (en) 1999-08-20

Family

ID=26661557

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98114660A HK1013299A1 (en) 1992-10-28 1998-12-22 Process for manufacturing crystals of growth hormone and crystals thereby obtained

Country Status (14)

Country Link
US (1) US5734026A (xx)
EP (1) EP0669934B1 (xx)
JP (1) JP3470135B2 (xx)
AT (1) ATE174602T1 (xx)
AU (1) AU679012B2 (xx)
CA (1) CA2147482C (xx)
DE (1) DE69322654T2 (xx)
DK (1) DK0669934T3 (xx)
ES (1) ES2126660T3 (xx)
FI (1) FI110609B (xx)
HK (1) HK1013299A1 (xx)
NO (1) NO320171B1 (xx)
SE (1) SE9302278D0 (xx)
WO (1) WO1994010192A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
AU8772498A (en) 1997-09-05 1999-03-29 Altus Biologics Inc. Carbohydrate crosslinked glycoprotein crystals
US6380357B2 (en) * 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
NZ534125A (en) * 2002-02-20 2006-11-30 Emisphere Tech Inc A formulation comprising a GLP-1 compound and a delivery agent
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
KR20050090430A (ko) * 2002-12-31 2005-09-13 알투스 파마슈티컬스 인코포레이티드 인간 성장 호르몬 결정 및 이것의 제조 방법
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) * 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY107450A (en) * 1990-06-04 1995-12-30 Schering Corp Method for preparing interferon alpha-2 crystals.
CA2085377A1 (en) * 1990-06-15 1991-12-16 Gerald Hammond Crystalline interleukin-4
DK168790D0 (xx) * 1990-07-13 1990-07-13 Novo Nordisk As
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone

Also Published As

Publication number Publication date
ATE174602T1 (de) 1999-01-15
NO320171B1 (no) 2005-11-07
DE69322654T2 (de) 1999-06-17
EP0669934B1 (en) 1998-12-16
JP3470135B2 (ja) 2003-11-25
DK0669934T3 (da) 1999-08-23
ES2126660T3 (es) 1999-04-01
EP0669934A1 (en) 1995-09-06
DE69322654D1 (de) 1999-01-28
SE9302278D0 (sv) 1993-07-02
NO951547L (no) 1995-04-24
US5734026A (en) 1998-03-31
AU5401194A (en) 1994-05-24
FI110609B (fi) 2003-02-28
JPH08505127A (ja) 1996-06-04
CA2147482C (en) 2003-09-23
WO1994010192A1 (en) 1994-05-11
CA2147482A1 (en) 1994-05-11
FI952021A (fi) 1995-04-27
FI952021A0 (fi) 1995-04-27
AU679012B2 (en) 1997-06-19
NO951547D0 (no) 1995-04-24

Similar Documents

Publication Publication Date Title
HK1013299A1 (en) Process for manufacturing crystals of growth hormone and crystals thereby obtained
DE69503604D1 (de) Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung
KR860002958A (ko) 살균제의 제법
DE69408666D1 (de) Risperidon pamoate
CA2031766A1 (en) 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insecticides and acaricides containing the same
FI911411A (fi) Kiteinen, kidevedetön laktitoli ja menetelmä sen valmistamiseksi sekä sen käyttö
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
FI98510B (fi) Vateriitti ja menetelmä sen valmistamiseksi
AR248407A1 (es) Un procedimiento para la preparacion de la forma monohidratada cristalina de una 1-carbacefalosporina.
IT1243801B (it) Intermedi per agenti chelanti con simmetria prefissata, e procedimentoper la loro preparazione
CY2257B1 (en) Process for preparing galanthamine derivatives by asymmetric reduction
MY103393A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
NZ513163A (en) Method for rapidly obtaining crystals with desirable morphologies
EP0551527B8 (en) Pyrroloazepine derivative
UA66832C2 (uk) Термодинамічно стійка модифікація і рематробану, спосіб одержання затравочних кристалів, спосіб одержання термодинамічно стійкої форми раматробану та фармацевтична композиція
GB1513840A (en) Phenoxycarboxylic acid aryloxy(thio)-carbonylaminomethyl esters and their use for regulating plant growth
EP0269739A4 (en) 1,5-DISUBSTITUTED IMIZADOLE.
FR2741348B1 (fr) Nouveau procede de fabrication du palatinitol
GB8718725D0 (en) Growing single crystal of compound semiconductor
JPS6485970A (en) Saccharoascorbic acid ester and production thereof

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081027